Literature DB >> 25731661

Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic".

Don C Des Jarlais1, Kamyar Arasteh2, Courtney McKnight2, Jonathan Feelemyer2, Holly Hagan3, Hannah L F Cooper4, Aimee N C Campbell5, Susan Tross5, David C Perlman2.   

Abstract

New York City has experienced the largest HIV epidemic among persons who use psychoactive drugs. We examined progress in placing HIV seropositive persons who inject drugs (PWID) and HIV seropositive non-injecting drug users (NIDU) onto antiretroviral treatment (ART) in New York City over the last 15 years. We recruited 3511 PWID and 3543 NIDU from persons voluntarily entering drug detoxification and methadone maintenance treatment programs in New York City from 2001 to 2014. HIV prevalence declined significantly among both PWID and NIDU. The percentage who reported receiving ART increased significantly, from approximately 50 % (2001-2005) to approximately 75 % (2012-2014). There were no racial/ethnic disparities in the percentages of HIV seropositive persons who were on ART. Continued improvement in ART uptake and TasP and maintenance of other prevention and care services should lead to an "End of the AIDS Epidemic" for persons who use heroin and cocaine in New York City.

Entities:  

Keywords:  Antiretroviral therapy; HIV; Non-injection drug users; Persons who inject drugs; Treatment as prevention

Mesh:

Substances:

Year:  2016        PMID: 25731661      PMCID: PMC4559487          DOI: 10.1007/s10461-015-1028-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  17 in total

1.  Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women.

Authors:  Tanya Telfair Sharpe; Lisa M Lee; Allyn K Nakashima; Laurie D Elam-Evans; Patricia L Fleming
Journal:  J Community Health       Date:  2004-04

2.  Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.

Authors:  D C Des Jarlais; T Perlis; S R Friedman; S Deren; T Chapman; J L Sotheran; S Tortu; M Beardsley; D Paone; L V Torian; S T Beatrice; E DeBernardo; E Monterroso; M Marmor
Journal:  Am J Public Health       Date:  1998-12       Impact factor: 9.308

3.  HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Samuel R Friedman
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

4.  Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients.

Authors:  Jeanette M Tetrault; Brent A Moore; Declan T Barry; Patrick G O'Connor; Richard Schottenfeld; David A Fiellin; Lynn E Fiellin
Journal:  J Subst Abuse Treat       Date:  2012-08-29

5.  HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Authors:  D C Des Jarlais; S R Friedman; D M Novick; J L Sotheran; P Thomas; S R Yancovitz; D Mildvan; J Weber; M J Kreek; R Maslansky
Journal:  JAMA       Date:  1989-02-17       Impact factor: 56.272

6.  Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

7.  Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?

Authors:  David C Perlman; Don C Des Jarlais; Jonathan Feelemyer
Journal:  J Addict Dis       Date:  2015

8.  Adaptations across clinical sites of an integrated treatment model for persons with HIV and substance abuse.

Authors:  Frank Lombard; Rae Jean Proescholdbell; Katherine Cooper; Laura Musselwhite; Evelyn Byrd Quinlivan
Journal:  AIDS Patient Care STDS       Date:  2009-08       Impact factor: 5.078

9.  Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program.

Authors:  Mary K Irvine; Stephanie A Chamberlin; Rebekkah S Robbins; Julie E Myers; Sarah L Braunstein; Beau J Mitts; Graham A Harriman; Fabienne Laraque; Denis Nash
Journal:  Clin Infect Dis       Date:  2014-10-09       Impact factor: 9.079

10.  Perceptions of drug users regarding hepatitis C screening and care: a qualitative study.

Authors:  Ashly E Jordan; Carmen L Masson; Pedro Mateu-Gelabert; Courtney McKnight; Nicole Pepper; Katie Bouche; Laura Guzman; Evan Kletter; Randy M Seewald; Don C Des-Jarlais; James L Sorensen; David C Perlman
Journal:  Harm Reduct J       Date:  2013-06-20
View more
  7 in total

1.  Trends in HIV Infection Among Persons Who Inject Drugs: United States and Puerto Rico, 2008-2013.

Authors:  Andrew John Mitsch; H Irene Hall; Aruna Surendera Babu
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

2.  Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.

Authors:  Ashly E Jordan; Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Denis Nash; David C Perlman
Journal:  Drug Alcohol Depend       Date:  2015-04-13       Impact factor: 4.492

Review 3.  ART uptake and adherence among women who use drugs globally: A scoping review.

Authors:  Jennifer L Glick; Aimee Huang; Rienna Russo; Belinda Jivapong; Vijayasundaram Ramasamy; Lori Rosman; Danielle Pelaez; Katherine H A Footer; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2020-08-02       Impact factor: 4.492

Review 4.  HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.

Authors:  Don C Des Jarlais; Thomas Kerr; Patrizia Carrieri; Jonathan Feelemyer; Kamyar Arasteh
Journal:  AIDS       Date:  2016-03-27       Impact factor: 4.177

5.  Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: a modelling study.

Authors:  Gregg S Gonsalves; Forrest W Crawford
Journal:  Lancet HIV       Date:  2018-09-13       Impact factor: 12.767

6.  Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users.

Authors:  Aimee N C Campbell; Don Des Jarlais; Cooper Hannah; Sarah Braunstein; Susan Tross; Laura Kersanske; Christine Borges; Martina Pavlicova; Kevin Jefferson; Howard Newville; Laurel Weaver; Margaret Wolff
Journal:  BMC Health Serv Res       Date:  2016-08-02       Impact factor: 2.655

7.  Racial Differences in HIV and HCV Risk Behaviors, Transmission, and Prevention Knowledge among Non-Treatment-Seeking Individuals with Opioid Use Disorder.

Authors:  Verena E Metz; Maria A Sullivan; Jermaine D Jones; Elizabeth Evans; Rachel Luba; Jonathan Vogelman; Sandra D Comer
Journal:  J Psychoactive Drugs       Date:  2016-12-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.